Funder: Health Resources in Action
Due Dates (Anticipated): December 2026: Invited Full Proposal online submission deadline (projected)
Funding Amounts: Up to $500,000 total per award ($250,000/year for 2 years); up to five awards per cycle; no indirect costs allowed.
Summary: Supports translational research to develop improved therapies for age-related macular degeneration, focusing on preclinical studies with potential for clinical impact.